Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

1-Year Survival After TAVR of Patients With Low-Flow, Low-Gradient and High-Gradient Aortic Valve Stenosis in Matched Study Populations.

Fischer-Rasokat U, Renker M, Liebetrau C, van Linden A, Arsalan M, Weferling M, Rolf A, Doss M, Möllmann H, Walther T, Hamm CW, Kim WK.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):752-763. doi: 10.1016/j.jcin.2019.01.233.

PMID:
31000012
2.

Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.

Liebetrau C, Gaede L, Kim WK, Arsalan M, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Kriechbaum S, Huber MT, van Linden A, Berkowitsch A, Dörr O, Nef H, Hamm CW, Walther T, Möllmann H.

Int J Cardiol. 2018 Aug 15;265:40-46. doi: 10.1016/j.ijcard.2018.02.037.

PMID:
29885699
3.

The ACURATE neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome.

Kim WK, Möllmann H, Liebetrau C, Renker M, Rolf A, Simon P, Van Linden A, Arsalan M, Doss M, Hamm CW, Walther T.

JACC Cardiovasc Interv. 2018 Sep 10;11(17):1721-1729. doi: 10.1016/j.jcin.2018.04.039. Epub 2018 May 23.

4.

Accuracy of device landing zone calcium volume measurement with contrast-enhanced multidetector computed tomography.

Kim WK, Renker M, Rolf A, Liebetrau C, Van Linden A, Arsalan M, Doss M, Rieck J, Opolski MP, Möllmann H, Walther T, Hamm CW.

Int J Cardiol. 2018 Jul 15;263:171-176. doi: 10.1016/j.ijcard.2018.02.042.

PMID:
29754916
5.

Randomized (CO)mparison of (TRI)fecta and (P)erimount Magna Ease Supraannular Aortic Xenografts-CO.TRI.P Study.

Van Linden A, Arsalan M, Körschgen T, Blumenstein J, Kempfert J, Hecker F, Walther T.

Thorac Cardiovasc Surg. 2019 Jun;67(4):266-273. doi: 10.1055/s-0038-1637011. Epub 2018 May 1.

PMID:
29715705
6.

Predictors and outcome of conversion to cardiac surgery during transcatheter aortic valve implantation.

Arsalan M, Kim WK, Van Linden A, Liebetrau C, Pollock BD, Filardo G, Renker M, Möllmann H, Doss M, Fischer-Rasokat U, Skwara A, Hamm CW, Walther T.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):267-272. doi: 10.1093/ejcts/ezy034.

PMID:
29506158
7.

Computed Tomography for Diagnosis and Classification of Bicuspid Aortic Valve Disease in Transcatheter Aortic Valve Replacement.

Kim WK, Gaede L, Husser O, Liebetrau C, Renker M, Rolf A, Fischer-Rasokat U, Möllmann S, Blumenstein J, Guenther E, Van Linden A, Arsalan M, Doss M, Loders S, Arnold M, Hamm CW, Walther T, Achenbach S, Möllmann H.

JACC Cardiovasc Imaging. 2018 Oct;11(10):1539-1540. doi: 10.1016/j.jcmg.2017.12.010. Epub 2018 Feb 14. No abstract available.

8.

TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model.

Arsalan M, Weferling M, Hecker F, Filardo G, Kim WK, Pollock BD, Van Linden A, Arsalan-Werner A, Renker M, Doss M, Kalbas S, Hamm CW, Liebetrau C, Mack MJ, Walther T.

EuroIntervention. 2018 Jan 20;13(13):1520-1526. doi: 10.4244/EIJ-D-17-00421.

9.

Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification.

Kim WK, Blumenstein J, Liebetrau C, Rolf A, Gaede L, Van Linden A, Arsalan M, Doss M, Tijssen JGP, Hamm CW, Walther T, Möllmann H.

Clin Res Cardiol. 2017 Dec;106(12):995-1004. doi: 10.1007/s00392-017-1149-3. Epub 2017 Aug 9.

PMID:
28795259
10.

Transfemoral aortic valve implantation using a self-expanding transcatheter heart valve without pre-dilation.

Kim WK, Liebetrau C, Renker M, Rolf A, Van Linden A, Arsalan M, Husser O, Möllmann H, Hamm C, Walther T.

Int J Cardiol. 2017 Sep 15;243:156-160. doi: 10.1016/j.ijcard.2017.05.092. Epub 2017 May 27.

PMID:
28579166
11.

Prognostic value of body mass index and body surface area on clinical outcomes after transcatheter aortic valve implantation.

Arsalan M, Filardo G, Kim WK, Squiers JJ, Pollock B, Liebetrau C, Blumenstein J, Kempfert J, Van Linden A, Arsalan-Werner A, Hamm C, Mack MJ, Moellmann H, Walther T.

Clin Res Cardiol. 2016 Dec;105(12):1042-1048. Epub 2016 Aug 17.

PMID:
27535139
12.

Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.

Kim WK, Praz F, Blumenstein J, Liebetrau C, Gaede L, Van Linden A, Hamm C, Walther T, Windecker S, Möllmann H.

Catheter Cardiovasc Interv. 2017 Jan;89(1):E38-E43. doi: 10.1002/ccd.26464. Epub 2016 Mar 4.

PMID:
26945934
13.

Cyclic changes in area- and perimeter-derived effective dimensions of the aortic annulus measured with multislice computed tomography and comparison with metric intraoperative sizing.

Kim WK, Meyer A, Möllmann H, Rolf A, Möllmann S, Blumenstein J, Van Linden A, Hamm CW, Walther T, Kempfert J.

Clin Res Cardiol. 2016 Jul;105(7):622-9. doi: 10.1007/s00392-016-0971-3. Epub 2016 Feb 18.

PMID:
26887376
14.

Myocardial injury associated with transcatheter aortic valve implantation (TAVI).

Kim WK, Liebetrau C, van Linden A, Blumenstein J, Gaede L, Hamm CW, Walther T, Möllmann H.

Clin Res Cardiol. 2016 May;105(5):379-87. doi: 10.1007/s00392-015-0949-6. Epub 2015 Dec 15. Review.

PMID:
26670909
15.

Simplified Transapical Aortic Valve Implantation Using the SAPIEN 3 Valve Without Preballooning.

Van Linden A, Kim WK, Liebetrau C, Doss M, Hecker F, Arsalan M, Blumenstein J, Möllmann H, Walther T.

Innovations (Phila). 2015 Nov-Dec;10(6):406-9. doi: 10.1097/IMI.0000000000000220.

PMID:
26655934
16.

AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair.

Ford JB, Baturin D, Burleson TM, Van Linden AA, Kim YM, Porter CC.

Oncotarget. 2015 Sep 29;6(29):28001-10. doi: 10.18632/oncotarget.4830.

17.

Transcatheter aortic valve implantation--update and evidence.

Van Linden A, Doss M, Arsalan M, Kim WK, Walther T.

Minim Invasive Ther Allied Technol. 2015;24(5):255-63. doi: 10.3109/13645706.2015.1047852. Epub 2015 May 13. Review.

PMID:
25966964
18.

Comparison of two valve systems for transapical aortic valve implantation: a propensity score-matched analysis.

Kempfert J, Meyer A, Kim WK, Van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T.

Eur J Cardiothorac Surg. 2016 Feb;49(2):486-92. doi: 10.1093/ejcts/ezv042. Epub 2015 Feb 10.

PMID:
25669644
19.

Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation.

Opolski MP, Kim WK, Liebetrau C, Walther C, Blumenstein J, Gaede L, Kempfert J, Van Linden A, Walther T, Hamm CW, Möllmann H.

Clin Res Cardiol. 2015 Jun;104(6):471-80. doi: 10.1007/s00392-014-0806-z. Epub 2015 Jan 6.

PMID:
25559245
20.

Image-based decision-making treatment of degenerated mitroflow and trifecta prostheses.

Van Linden A, Blumenstein J, Möllmann H, Kim WK, Walther T, Kempfert J.

Ann Thorac Surg. 2014 Nov;98(5):1809-13. doi: 10.1016/j.athoracsur.2014.07.059. Epub 2014 Oct 30.

PMID:
25441789
21.

Transfemoral aortic valve implantation of Edwards SAPIEN XT without predilatation is feasible.

Möllmann H, Kim WK, Kempfert J, Blumenstein J, Liebetrau C, Nef H, Van Linden A, Walther T, Hamm C.

Clin Cardiol. 2014 Nov;37(11):667-71. doi: 10.1002/clc.22318. Epub 2014 Jul 31.

22.

Detection of myocardial injury by CMR after transcatheter aortic valve replacement.

Kim WK, Rolf A, Liebetrau C, Van Linden A, Blumenstein J, Kempfert J, Bachmann G, Nef H, Hamm C, Walther T, Möllmann H.

J Am Coll Cardiol. 2014 Jul 29;64(4):349-57. doi: 10.1016/j.jacc.2014.03.052.

23.

First experience without pre-ballooning in transapical aortic valve implantation: a propensity score-matched analysis.

Kempfert J, Meyer A, Kim WK, van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T.

Eur J Cardiothorac Surg. 2015 Jan;47(1):31-8; discussion 38. doi: 10.1093/ejcts/ezu097. Epub 2014 Mar 27.

PMID:
24674906
24.

Manual versus automatic detection of aortic annulus plane in a computed tomography scan for transcatheter aortic valve implantation screening.

Van Linden A, Kempfert J, Blumenstein J, Möllmann H, Kim WK, Alkaya S, Hamm C, Walther T.

Eur J Cardiothorac Surg. 2014 Aug;46(2):207-12; discussion 212. doi: 10.1093/ejcts/ezt600. Epub 2014 Jan 14.

PMID:
24431165
25.

Transcatheter Heart Valves: Specific Characteristics and Potential Shortcomings.

Blumenstein J, Van Linden A, Moellmann H, Walther T, Kempfert J.

Curr Cardiol Rev. 2013 Dec 2. [Epub ahead of print]

PMID:
24313646
26.

Recent advances in transcatheter aortic valve implantation: novel devices and potential shortcomings.

Blumenstein J, Liebetrau C, Van Linden A, Moellmann H, Walther T, Kempfert J.

Curr Cardiol Rev. 2013 Nov;9(4):274-80.

27.

Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality.

Van Linden AA, Baturin D, Ford JB, Fosmire SP, Gardner L, Korch C, Reigan P, Porter CC.

Mol Cancer Ther. 2013 Dec;12(12):2675-84. doi: 10.1158/1535-7163.MCT-13-0424. Epub 2013 Oct 11.

28.

Sutureless transapical access and closure to facilitate transapical transcatheter aortic valve implantation: first-in-human use.

Blumenstein J, Kempfert J, Van Linden A, Arsalan M, Mollmann H, Kim WK, Walther T.

J Am Coll Cardiol. 2013 Aug 20;62(8):763. doi: 10.1016/j.jacc.2013.02.096. Epub 2013 Jun 14. No abstract available.

29.

Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest.

Leick J, Liebetrau C, Szardien S, Fischer-Rasokat U, Willmer M, van Linden A, Blumenstein J, Nef H, Rolf A, Arlt M, Walther T, Hamm C, Möllmann H.

Clin Res Cardiol. 2013 Sep;102(9):661-9. doi: 10.1007/s00392-013-0580-3. Epub 2013 May 9.

PMID:
23657432
30.

First-in-man evaluation of the transapical APICA ASC™ access and closure device: the initial 10 patients.

Blumenstein J, Kempfert J, Van Linden A, Arsalan M, Schmidt SK, Mollmann H, Kim WK, Thourani V, Walther T.

Eur J Cardiothorac Surg. 2013 Dec;44(6):1057-62; discussion 1062. doi: 10.1093/ejcts/ezt198. Epub 2013 Apr 5.

PMID:
23562938
31.

Aortic stenosis in high-risk patients. Surgical therapy.

Walther T, Arsalan M, Blumenstein J, van Linden A, Kempfert J.

Herz. 2013 Mar;38(2):112-7. doi: 10.1007/s00059-012-3746-2.

PMID:
23471357
32.

DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.

Blumenstein JM, Van Linden A, Moellmann H, Seeburger J, Rastan A, Kim WK, Mohr FW, Kempfert J, Walther T.

Thorac Cardiovasc Surg. 2013 Aug;61(5):409-13. doi: 10.1055/s-0032-1329270. Epub 2012 Dec 17.

PMID:
23247690
33.

Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard.

Walther T, Blumenstein J, van Linden A, Kempfert J.

Heart. 2012 Nov;98 Suppl 4:iv23-9. doi: 10.1136/heartjnl-2012-302399. Review.

PMID:
23143122
34.

Rescue valve-in-valve implantations in second generation transapical transcatheter aortic valve prostheses.

Van Linden A, Blumenstein J, Walther T, Möllmann H, Kim WK, Hamm C, Kempfert J.

Clin Res Cardiol. 2013 Mar;102(3):241-3. doi: 10.1007/s00392-012-0520-7. Epub 2012 Nov 6. No abstract available.

PMID:
23128831
35.

Experimental evaluation of a new apical access and closure device.

Blumenstein J, Van Linden A, Arsalan M, Voss S, Moellmann H, Liebetrau C, Thourani VH, Walther T, Kempfert J.

Ann Thorac Surg. 2012 Nov;94(5):1706-9. doi: 10.1016/j.athoracsur.2012.08.102.

PMID:
23098947
36.

Early SAPIEN transcatheter heart valve dysfunction due to tissue ingrowth in an octogenarian.

Blumenstein J, Van Linden A, Kim WK, Skwara W, Schoenburg M, Arsalan M, Moellmann H, Niederhagen M, Kempfert J, Walther T.

Clin Res Cardiol. 2013 Mar;102(3):237-40. doi: 10.1007/s00392-012-0518-1. Epub 2012 Oct 25. No abstract available.

PMID:
23097135
37.

Prosthesis-patient mismatch after transcatheter aortic valve implantation using the Edwards SAPIEN™ prosthesis.

Van Linden A, Kempfert J, Blumenstein J, Rastan A, Holzhey D, Lehmann S, Mohr FW, Walther T.

Thorac Cardiovasc Surg. 2013 Aug;61(5):414-20. doi: 10.1055/s-0032-1311534. Epub 2012 Jul 12.

PMID:
22791205
38.

Retrograde, transsubclavian implantation of a SAPIEN XT™ aortic valve prosthesis with the Edwards NovaFlex+™ system.

Blumenstein J, Van Linden A, Kempfert J, Kim WK, Liebetrau C, Hamm C, Nef H, Walther T, Moellmann H.

Clin Res Cardiol. 2012 Sep;101(9):773-5. doi: 10.1007/s00392-012-0460-2. Epub 2012 May 3. No abstract available.

PMID:
22552833
39.

Aortic annulus sizing: echocardiographic versus computed tomography derived measurements in comparison with direct surgical sizing.

Kempfert J, Van Linden A, Lehmkuhl L, Rastan AJ, Holzhey D, Blumenstein J, Mohr FW, Walther T.

Eur J Cardiothorac Surg. 2012 Oct;42(4):627-33. doi: 10.1093/ejcts/ezs064. Epub 2012 Mar 7.

PMID:
22402450
40.

Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.

Porter CC, Kim J, Fosmire S, Gearheart CM, van Linden A, Baturin D, Zaberezhnyy V, Patel PR, Gao D, Tan AC, DeGregori J.

Leukemia. 2012 Jun;26(6):1266-76. doi: 10.1038/leu.2011.392. Epub 2012 Jan 13.

41.

Transapical access: current status and future directions.

Blumenstein J, Van Linden A, Arsalan M, Moellmann H, Liebtrau C, Walther T, Kempfert J.

Expert Rev Med Devices. 2012 Jan;9(1):15-22. doi: 10.1586/ERD.11.66. Review.

PMID:
22145837
42.

Current perspectives in endoscopic vessel harvesting for coronary artery bypass grafting.

Kempfert J, Rastan A, Leontyev S, Luduena M, Van Linden A, Arsalan M, Blumenstein J, Holzhey D, Lehmann S, Mohr FW, Walther T.

Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1481-8. doi: 10.1586/erc.11.151. Review.

PMID:
22059796
43.

Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients.

Kempfert J, Rastan A, Holzhey D, Linke A, Schuler G, van Linden A, Blumenstein J, Mohr FW, Walther T.

Circulation. 2011 Sep 13;124(11 Suppl):S124-9. doi: 10.1161/CIRCULATIONAHA.110.013425.

PMID:
21911801
44.

Transcatheter aortic valve implantation transapical: step by step.

Walther T, Möllmann H, van Linden A, Kempfert J.

Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):55-61. doi: 10.1053/j.semtcvs.2011.05.006.

PMID:
21807300
45.

Endurance and performance of two different concepts for left ventricular stimulation with bipolar epicardial leads in long-term follow-up.

Burger H, Kempfert J, van Linden A, Szalay Z, Schoenburg M, Walther T, Ziegelhoeffer T.

Thorac Cardiovasc Surg. 2012 Feb;60(1):70-7. doi: 10.1055/s-0031-1280066. Epub 2011 Jul 25.

PMID:
21789760
46.

Transapical aortic valve implantation off-pump in patients with impaired left ventricular function.

Van Linden A, Kempfert J, Blumenstein J, Holzhey D, Rastan AJ, Mohr FW, Walther T.

Ann Thorac Surg. 2011 Jul;92(1):18-23. doi: 10.1016/j.athoracsur.2011.03.041.

PMID:
21718826
47.

A second prosthesis as a procedural rescue option in trans-apical aortic valve implantation.

Kempfert J, Rastan AJ, Schuler G, Linke A, Holzhey D, van Linden A, Mohr FW, Walther T.

Eur J Cardiothorac Surg. 2011 Jul;40(1):56-60. doi: 10.1016/j.ejcts.2011.03.020. Epub 2011 May 6.

PMID:
21549613
48.

The evolution of transapical aortic valve implantation and new perspectives.

Kempfert J, Van Linden A, Holzhey D, Rastan A, Blumenstein J, Mohr FW, Walther T.

Minim Invasive Ther Allied Technol. 2011 Apr;20(2):107-16. doi: 10.3109/13645706.2011.558101. Review.

PMID:
21417844
49.

Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients.

Van Linden A, Kempfert J, Rastan AJ, Holzhey D, Blumenstein J, Schuler G, Mohr FW, Walther T.

Eur J Cardiothorac Surg. 2011 Jun;39(6):835-42; discussion 842-3. doi: 10.1016/j.ejcts.2010.11.034. Epub 2010 Dec 24.

PMID:
21186126
50.

Transapical aortic valve implantation: therapy of choice for patients with aortic stenosis and porcelain aorta?

Kempfert J, Van Linden A, Linke A, Schuler G, Rastan A, Lehmann S, Lehmkuhl L, Mohr FW, Walther T.

Ann Thorac Surg. 2010 Nov;90(5):1457-61. doi: 10.1016/j.athoracsur.2010.06.080.

PMID:
20971240

Supplemental Content

Loading ...
Support Center